Product Information
NORTRIPTYLINE HCL 25 MG CAP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1561 per EA under NDC 75907007005. Its NADAC has been published 132 times since Mar 27, 2024.
FDA first approved this application on Mar 30, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907007005
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073556FDA Approved
3/30/1992
TE Code
AB
On Market Since
11/17/2023
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE HCL 25 MG CAP has been published 132 times since Mar 27, 2024, and over the history we have for it it has risen 70.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1561 per EA |
|---|---|
| All-time high | $0.1710 (Sep 10, 2025) |
| All-time low | $0.0732 (May 22, 2024) |
| 52-week high | $0.1700 |
| 52-week low | $0.1509 |
| Median price | $0.1509 |
| Average price | $0.1359 |
| Largest weekly change | +23.5% (Aug 21, 2024) |
| Weeks tracked | 132 |
| Tracking since | Mar 27, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nortriptyline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE HCL 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 25 MG CAP, manufactured by Dr. Reddy's Laboratories Inc., is $0.1561 per EA (NDC 75907007005), effective Sep 30, 2026.
How has the price of NORTRIPTYLINE HCL 25 MG CAP changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 25 MG CAP has risen 70.1%. It has been tracked across 132 weekly CMS publications since Mar 27, 2024.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 25 MG CAP?
Since Mar 27, 2024, the NADAC for NORTRIPTYLINE HCL 25 MG CAP has ranged from a low of $0.0732 (May 22, 2024) to a high of $0.1710 (Sep 10, 2025), with a median of $0.1509 per EA.
Are there cheaper alternatives to NORTRIPTYLINE HCL 25 MG CAP?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORTRIPTYLINE HCL 25 MG CAP, is $0.1047 per EA — about 33% below NORTRIPTYLINE HCL 25 MG CAP.
Who manufactures NORTRIPTYLINE HCL 25 MG CAP?
NORTRIPTYLINE HCL 25 MG CAP (NDC 75907007005) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.